Indications |
Oral Depression Adult: As hydrochloride: Initially, 75 mg daily in divided doses increased gradually to 150-200 mg daily if necessary; 300 mg daily given in severely depressed patients. Elderly: As hydrochloride: Initially, 10 mg at night gradually increased to 30-50 mg daily. Oral Nocturnal enuresis Child: As hydrochloride: 6-7 yr (20-25 kg): 25 mg; 8-11 yr (25-35 kg): 25-50 mg; >11 yr (35-54 kg): 50-75 mg. Dose to be taken once daily before bedtime for up to 3 mth. |
Contraindications |
Post MI, heart block/arrhythmias; mania; porphyria; severe hepatic impairment. |
Warnings / Precautions |
Epilepsy; children, elderly, pregnancy and lactation; cardiac disease; DM; prostatic hyperplasia; angle-closure glaucoma; phaeochromocytoma. Monitor for increased suicidality during early treatment. Withdraw gradually. |
Adverse Reactions |
Sinus tachycardia, AV/bundle-branch block, postural hypotension, dry mouth, wt loss/gain, constipation, urinary hesitancy/retention, impotence; blurring of vision, exacerbation of glaucoma, liver dysfunction, tremors. Potentially Fatal: Rarely, agranulocytosis. |
Overdose Reactions |
Symptoms include CNS stimulation followed by severe CNS depression; tachycardia and conduction disturbances; peripheral anticholinergic effects and seizures. |
Drug Interactions |
Increased plasma levels and effects with quinidine, cimetidine, SSRIs, propafenone, flecainide. Reduced plasma levels with barbiturates, phenytoin. May increase effects of anticholinergic drugs. Severe orthostatic hypotension with altretamine. Causes drowsiness and impaired performance in combination with alcohol. Potentially Fatal: Severe hypertension with adrenaline, noradrenaline and methylphenidate. Reduces hypotensive effects of guanethidine, bethanidine, debrisoquine, bretylium, methyldopa and clonidine. Possible serotonin syndrome with MAOIs, separate admin by 3 wk. See Below for More imipramine Drug Interactions |
Mechanism of Actions |
Imipramine inhibits noradrenaline re-uptake and, to a lesser extent, that of serotonin. Absorption: Readily absorbed from the GI tract (oral). Peak plasma concentrations are achieved within 1-2 hr after oral admin. Distribution: Extensively protein-bound and widely distributed with an average volume of distribution of 21 l/kg. Both imipramine and desipramine cross the blood-brain barrier; the placenta and can enter breast milk. Metabolism: Converted to primary active metabolite desipramine by demethylation during extensive first-pass hepatic metabolism. Excretion: Via urine (as metabolites), faeces (small amounts); 9-28 hr (elimination half-life). |
Administration |
May be taken with or without food. |
ATC Classification |
N06AA02 - imipramine ; Belongs to the class of non-selective monoamine reuptake inhibitors. Used in the management of depression. |
Available As |
|
Imipramine
Post Review about Imipramine Click here to cancel reply.
Imipramine Containing Brands
Imipramine is used in following diseases
Drug - Drug Interactions of Imipramine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.